Reply to “Conceptual interpretation and clinical applicability of A systematic review and meta-analysis about prognostic value of Apolipoproteins in COVID-19 patients”

dc.date.accessioned2022-06-25T20:36:42Z
dc.date.available2022-06-25T20:36:42Z
dc.date.created2022-06-25T20:36:42Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/11860
dc.identifierhttps://doi.org/10.1016/j.tmaid.2021.102249
dc.description.abstractWe disagree with what the authors mentioned about interpreting the odds ratio (OR) of the ApoB/A1 ratio. In the interpretation of a measure of association estimated by meta-analysis (MA), there are two considerations: statistical significance, evaluated using p-values and confidence intervals (CI), and clinical significance, evaluated using direction and magnitude of effect (strength of association)...
dc.languageeng
dc.publisherElsevier
dc.relationTravel Medicine and Infectious Disease
dc.relation1873-0442
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectreply
dc.subjectConceptual interpretation
dc.subjectclinical applicability
dc.subjectsystematic review
dc.subjectApolipoproteins
dc.subjectCOVID-19 patients
dc.titleReply to “Conceptual interpretation and clinical applicability of A systematic review and meta-analysis about prognostic value of Apolipoproteins in COVID-19 patients”
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución